Dhanvantri Jeevan Rekha Ltd (BSE: 531043) is a Meerut, Uttar Pradesh-based company in the Hospitals and Healthcare Centers industry. With a market capitalisation of ₹10 Cr, it ranks #5,074 by market cap among the 6,137 Indian listed companies on FinBizNet, and #40 of 42 in Hospitals and Healthcare Centers. At ₹23.56 (as of 25 Oct 2026), the share price is 21.5% below its 52-week high of ₹30.00 and 20.6% above its 52-week low of ₹19.53. The share price is down 6.1% over one year and down 7.5% over three months.
| Current Price | ₹23.56 |
|---|---|
| Market Cap | ₹10 Cr |
| BSE Code | 531043 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Facilities > Hospitals and Healthcare Centers |
| P/E Ratio | 24.9 |
| Return on Equity | 5.16% |
| Return on Assets | 1.17% |
| 52-Week Range | ₹19.53 – ₹30.00 |
| 1-Year Price Change | -6.1% |
| 3-Month Price Change | -7.5% |
| Beta (1Y) | -0.15 |
| Dividend Yield | 0.00% |
| Headquarters | Meerut, Uttar Pradesh |
| Website | www.djrl.org.in |
Dhanvantri Jeevan Rekha Limited engages in the provision of medical and healthcare services in India. It offers diagnostic and therapeutic services. The company also provides specialty services, such as Cardiology, Gastroenterology, Neurology, Urology, Nephrology, Internal Medicine, Pulmonology, and other diagnostic services. In addition, the company operates a cath lab that provides angiography, angioplasty, pacemaker implantation, valvuloplasty services, etc. Dhanvantri Jeevan Rekha Limited was incorporated in 1993 and is based in Meerut, India.
1. Healthcare Facilities & Services-This segment operates a hospital and medical diagnostic centre. It provides diagnostic and therapeutic services in the areas of urology, gastroenterology, cardiology, neurology, and radiology, including magnetic resonance imaging.
1. Healthcare Facilities & Services-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Limited | ₹1,13,446 Cr | 57 | 21.50% | ₹7,044 Cr | -1.3% |
| Manipal Health Enterprises Ltd | ₹84,500 Cr | 82.1 | — | ₹3,091 Cr | — |
| Max Healthcare Institute Ltd | ₹82,242 Cr | 56.3 | 14.33% | ₹2,366 Cr | -30.7% |
| Aster Dm Healthcare Limited (Asterdm) | ₹58,702 Cr | 88.7 | 10.07% | ₹1,311 Cr | -7.8% |
| Fortis Healthcare Ltd. | ₹55,603 Cr | 53.3 | 11.01% | ₹2,545 Cr | -34.9% |
| Global Health Ltd (Medanta) | ₹33,340 Cr | 60 | 15.03% | ₹1,304 Cr | -15.1% |
| Krishna Institute Of Medical Science (KIMS) | ₹27,434 Cr | 112.5 | 9.72% | ₹1,180 Cr | -9.4% |
| Dr. Agarwal's Health Care Limited | ₹14,767 Cr | 112 | 8.31% | ₹614 Cr | -9.3% |
| Dhanvantri Jeevan Rekha Ltd | ₹10 Cr | 24.9 | 5.16% | — | -6.1% |
Listed by market capitalisation. Ratios are shown for context only.
Dhanvantri Jeevan Rekha Ltd is trading at ₹23.56, with a market capitalisation of ₹10 Cr.
Dhanvantri Jeevan Rekha Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Hospitals and Healthcare Centers).
Dhanvantri Jeevan Rekha Ltd has a P/E of 24.9 and a return on equity of 5.16%.
Dhanvantri Jeevan Rekha Ltd is listed on the BSE under the scrip code 531043.
Dhanvantri Jeevan Rekha Ltd's share price is down 6.1% over one year and down 7.5% over three months. Its 52-week range is ₹19.53 to ₹30.00.
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.